PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more
Market Cap & Net Worth: PolyNovo Limited (CALZF)
PolyNovo Limited (PINK:CALZF) has a market capitalization of $424.87 Million ($424.87 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #11806 globally and #5180 in its home market, demonstrating a -23.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PolyNovo Limited's stock price $0.62 by its total outstanding shares 690842991 (690.84 Million).
PolyNovo Limited Market Cap History: 2015 to 2025
PolyNovo Limited's market capitalization history from 2015 to 2025. Data shows growth from $55.27 Million to $424.87 Million (18.00% CAGR).
PolyNovo Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PolyNovo Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.34x
PolyNovo Limited's market cap is 3.34 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
32.15x
PolyNovo Limited's market cap is 32.15 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $145.08 Million | $3.28 Million | -$3.06 Million | 44.27x | N/A |
| 2017 | $227.98 Million | $3.62 Million | -$5.01 Million | 62.98x | N/A |
| 2018 | $303.97 Million | $6.55 Million | -$5.97 Million | 46.38x | N/A |
| 2019 | $1.00 Billion | $14.04 Million | -$3.19 Million | 71.33x | N/A |
| 2020 | $1.97 Billion | $22.16 Million | -$4.19 Million | 88.87x | N/A |
| 2021 | $794.47 Million | $29.16 Million | -$4.61 Million | 27.25x | N/A |
| 2022 | $822.10 Million | $41.44 Million | -$1.19 Million | 19.84x | N/A |
| 2023 | $552.67 Million | $65.24 Million | -$4.92 Million | 8.47x | N/A |
| 2024 | $1.04 Billion | $103.19 Million | $5.26 Million | 10.04x | 196.97x |
| 2025 | $424.87 Million | $127.24 Million | $13.21 Million | 3.34x | 32.15x |
Competitor Companies of CALZF by Market Capitalization
Companies near PolyNovo Limited in the global market cap rankings as of March 19, 2026.
Key companies related to PolyNovo Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
PolyNovo Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, PolyNovo Limited's market cap moved from $55.27 Million to $ 424.87 Million, with a yearly change of 18.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $424.87 Million | -59.00% |
| 2024 | $1.04 Billion | +87.50% |
| 2023 | $552.67 Million | -32.77% |
| 2022 | $822.10 Million | +3.48% |
| 2021 | $794.47 Million | -59.65% |
| 2020 | $1.97 Billion | +96.55% |
| 2019 | $1.00 Billion | +229.55% |
| 2018 | $303.97 Million | +33.33% |
| 2017 | $227.98 Million | +57.14% |
| 2016 | $145.08 Million | +162.50% |
| 2015 | $55.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of PolyNovo Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $424.87 Million USD |
| MoneyControl | $424.87 Million USD |
| MarketWatch | $424.87 Million USD |
| marketcap.company | $424.87 Million USD |
| Reuters | $424.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.